-
Should You Consider Investing in Supernus Pharmaceuticals (SUPN)?
18 Aug 2021 16:54 GMT
… , the fund mentioned Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN … controversial as the medical treatment options for children … the USA alone, doctors write 75 million prescriptions … States Food and Drug Administration (FDA) so far. Strattera (Atomoxetine) …
-
Supernus Pharmaceuticals Inc (SUPN) Q1 2021 Earnings Call Transcript
06 May 2021 03:01 GMT
… Investor Relations representative for Supernus Pharmaceuticals. You may begin.
Peter … to the FDA for Qelbree for the treatment of ADHD … Shire [Phonetic] defending against Strattera with ADDERALL XR and … it than just prescribing a pill, obviously. So, that …
-
OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
22 Apr 2021 12:00 GMT
… of several oral liquid medications in neuroscience that … trials in adults (age 18 and older), and one maintenance trial … to improve upon existing treatment options, are forward- … .com. SOURCE OWP Pharmaceuticals, Inc.
1. STRATTERA® (atomoxetine hydrochloride) …
-
Psychiatric Drugs and Side Effects - The Unseen Hand Behind Violence in America
13 Jan 2021 07:38 GMT
… drugs contain FDA-required warnings to doctors … medication used to treat nicotine addiction), zolpidem, montelukast, and all antidepressant drugs … Drug Administration called for stronger warnings on Adderall, Concerta, Ritalin and Strattera … drug treatment of …
-
Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing
08 Nov 2020 14:59 GMT
… Pharmaceuticals Inc. (SUPN)
The FDA decision on Supernus' drug … many years as an antidepressant.
If approved, SPN … ) Strattera, the first non-stimulant treatment for ADHD. Strattera, … drugs are the most commonly prescribed medications for the treatment …
-
Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates
03 Nov 2020 21:32 GMT
… on Spectrum Pharmaceuticals, Inc.'s (NASDAQ: SPPI) treatment candidate … as an alternative to Strattera, the only other serotonin … 's Progeria Drug Pass The FDA Muster?
Company: Eiger … Label Expansions For Flu Medication
Company: Roche Holdings (OTC …
-
Week Ahead In Pharma: COVID-19 Data Readout, FDA Decisions, CTAD Presentation
01 Nov 2020 10:29 GMT
… Supernus Pharmaceuticals Inc. (SUPN)
Supernus awaits the FDA decision on its drug candidate … many years as an antidepressant.
If approved, SPN-812 … FDA nod simultaneously.
While stimulant drugs are the most commonly prescribed medications for the treatment …
-
The ADHD debate: To medicate or not to medicate, that is the question
22 Aug 2020 08:30 GMT
… Strattera.
In some cases certain types of blood pressure medication … might also be a antidepressant prescription depending on the … ADD). Talking to your doctor to identify the type …
Homeopathically, there are certain remedies that describe nervous, anxious …
-
RespireRx Pharmaceuticals Inc. Announces Extension to Long-Term Employment Contract with Tim Jones as President and Chief Executive Officer
03 Aug 2020 19:11 GMT
… Vice President of Global Pharmaceutical and Medical OTC at Purisys LLC … . There are no approved drug treatments for OSA. Pending the … Phase 2 human clinical trial of CX717 in adults … scheduled by the FDA. Non-stimulants, such as Strattera® (atomoxetine) tend …
-
RespireRx Pharmaceuticals Inc. Announces Appointment of Timothy Jones as President and Chief Executive Officer
06 May 2020 13:25 GMT
… Vice President of Global Pharmaceutical and Medical OTC at Purisys LLC … . There are no approved drug treatments for OSA. Pending the … Phase 2 human clinical trial of CX717 in adults … scheduled by the FDA. Non-stimulants, such as Strattera® (atomoxetine) tend …
About
© 1995-2021